GUIDED THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $205.00K.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $6.00K.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $0.00.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $178.00K.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $567.00K, a 32.10% decline from fiscal 2024.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $835.00K.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2016 was $50.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $567.00K 10-K · filed 2026-03-31 | |
| 2025-03-31 | $205.00K 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $835.00K 10-K · filed 2026-03-31 | |
| 2020-09-30 | $6.00K 10-Q/A · filed 2020-11-05 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-08-20 | |
| 2020-03-31 | $178.00K 10-Q/A · filed 2021-08-18 | |
| 2016-12-31 | $50.00K 10-K/A · filed 2018-04-20 |